475 related articles for article (PubMed ID: 24666287)
1. Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography.
Lindner S; Michler C; Leidner S; Rensch C; Wängler C; Schirrmacher R; Bartenstein P; Wängler B
Bioconjug Chem; 2014 Apr; 25(4):738-49. PubMed ID: 24666287
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
3. One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
Wängler C; Waser B; Alke A; Iovkova L; Buchholz HG; Niedermoser S; Jurkschat K; Fottner C; Bartenstein P; Schirrmacher R; Reubi JC; Wester HJ; Wängler B
Bioconjug Chem; 2010 Dec; 21(12):2289-96. PubMed ID: 21082773
[TBL] [Abstract][Full Text] [Related]
4. Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.
Litau S; Niedermoser S; Vogler N; Roscher M; Schirrmacher R; Fricker G; Wängler B; Wängler C
Bioconjug Chem; 2015 Dec; 26(12):2350-9. PubMed ID: 26420336
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
6. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
7. (18)F-glyco-RGD peptides for PET imaging of integrin expression: efficient radiosynthesis by click chemistry and modulation of biodistribution by glycosylation.
Maschauer S; Haubner R; Kuwert T; Prante O
Mol Pharm; 2014 Feb; 11(2):505-15. PubMed ID: 24325589
[TBL] [Abstract][Full Text] [Related]
8. Novel (64)Cu- and (68)Ga-labeled RGD conjugates show improved PET imaging of α(ν)β(3) integrin expression and facile radiosynthesis.
Dumont RA; Deininger F; Haubner R; Maecke HR; Weber WA; Fani M
J Nucl Med; 2011 Aug; 52(8):1276-84. PubMed ID: 21764795
[TBL] [Abstract][Full Text] [Related]
9. Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups.
Richter S; Wuest M; Bergman CN; Way JD; Krieger S; Rogers BE; Wuest F
Bioconjug Chem; 2015 Feb; 26(2):201-12. PubMed ID: 25572982
[TBL] [Abstract][Full Text] [Related]
10. Metabolically Stabilized (68)Ga-NOTA-Bombesin for PET Imaging of Prostate Cancer and Influence of Protease Inhibitor Phosphoramidon.
Richter S; Wuest M; Bergman CN; Krieger S; Rogers BE; Wuest F
Mol Pharm; 2016 Apr; 13(4):1347-57. PubMed ID: 26973098
[TBL] [Abstract][Full Text] [Related]
11. (18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging.
Pourghiasian M; Liu Z; Pan J; Zhang Z; Colpo N; Lin KS; Perrin DM; Bénard F
Bioorg Med Chem; 2015 Apr; 23(7):1500-6. PubMed ID: 25757604
[TBL] [Abstract][Full Text] [Related]
12. Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.
Liu Z; Yan Y; Chin FT; Wang F; Chen X
J Med Chem; 2009 Jan; 52(2):425-32. PubMed ID: 19113865
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks.
Höhne A; Mu L; Honer M; Schubiger PA; Ametamey SM; Graham K; Stellfeld T; Borkowski S; Berndorff D; Klar U; Voigtmann U; Cyr JE; Friebe M; Dinkelborg L; Srinivasan A
Bioconjug Chem; 2008 Sep; 19(9):1871-9. PubMed ID: 18754574
[TBL] [Abstract][Full Text] [Related]
14. Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.
Schroeder RP; van Weerden WM; Krenning EP; Bangma CH; Berndsen S; Grievink-de Ligt CH; Groen HC; Reneman S; de Blois E; Breeman WA; de Jong M
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1257-66. PubMed ID: 21431398
[TBL] [Abstract][Full Text] [Related]
15. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors.
Ma Y; Liang S; Guo J; Guo R; Wang H
J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311
[TBL] [Abstract][Full Text] [Related]
16. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
17. Characterization and evaluation of DOTA-conjugated Bombesin/RGD-antagonists for prostate cancer tumor imaging and therapy.
Stott Reynolds TJ; Schehr R; Liu D; Xu J; Miao Y; Hoffman TJ; Rold TL; Lewis MR; Smith CJ
Nucl Med Biol; 2015 Feb; 42(2):99-108. PubMed ID: 25459113
[TBL] [Abstract][Full Text] [Related]
18. PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.
Lindner S; Michler C; Wängler B; Bartenstein P; Fischer G; Schirrmacher R; Wängler C
Bioconjug Chem; 2014 Mar; 25(3):489-500. PubMed ID: 24533789
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and Preliminary Evaluation of Dual Target PET Probe [18F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer.
Chen Z; Fu H; Wu H; Huang J; Yao L; Zhang X; Li Y
Anticancer Agents Med Chem; 2020; 20(13):1548-1557. PubMed ID: 32329699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
